Emergency vaccine approval not legal option in Switzerland
The emergency approval process being used by some countries to speed up the roll-out of Covid-19 vaccines is not a legal option in Switzerland, its medicines approval agency said on Friday.
This content was published on
2 minutes
Keystone-SDA/Reuters/Swissmedic/ilj
Español
es
Vacunas: Suiza descarta aprobaciones de emergencia
The statement comes as the regulatory authority in the United States, the FDA, gets ready to decide on an emergency approval (Emergency Use Authorisation) for the use of the coronavirus vaccine from Pfizer/BioNTech.
“Swissmedic works closely with international partner authorities and reviews all applications for Covid-19 vaccines as a matter of urgency and in a ‘rolling’ procedure,” the Swiss agency for therapeutic products said in a statement on FridayExternal link.
Swissmedic said it had received additional details from companies on their Covid-19 vaccines that would enable it to issue authorisations quickly once sufficient data on safety, efficacy and quality were available.
However, it added: “An emergency approval for vaccines is not a legal option in Switzerland,” the agency said, ruling out what it called “premature vaccinations” for the country.
“The safety of the Swiss population has top priority,” the statement said.
Britain became the first country to approve and roll out a Covid-19 19 vaccine from Pfizer and its partner BioNTech. The first vaccination took place on December 8.
Switzerland said on December 7 that it had signed a contract with Pfizer and BioNTech to deliver 3 million doses of their vaccine. It has also signed agreements with Moderna and AstraZeneca.
The Alpine country now has 15.8 million doses of vaccines on order from the three different manufacturers, pending approval from the health regulator.
More
More
Switzerland secures three million doses of Pfizer/BioNTech vaccine
This content was published on
Some 4.5 million doses of another vaccine have already been agreed with United States pharma company Moderna and another 5.3 million doses from the British-Swedish firm AstraZeneca. The government said on MondayExternal link that membership of the World Health Organization COVAXExternal link initiative grants vaccine coverage to 20% of the Swiss population. The Pfizer/BioNTech vaccine would require…
First large-scale alpine solar plant approved in Switzerland
This content was published on
The approval was met with satisfaction by the project's organisers, but it also brings with it a certain amount of pressure.
Medieval squirrels may have ‘helped spread leprosy’
This content was published on
An examination of squirrel remains in the United Kingdom has opened up interesting questions and possibilities in terms of the history of the disease.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
Incomplete data stalls Swiss authorisation of Covid-19 vaccines
This content was published on
Switzerland’s medical regulator says it lacks the necessary information to sign off on three different vaccines ordered by the government.
This content was published on
With a death toll of over 5,000, Switzerland (population 8.5 million) expects to launch its coronavirus vaccination campaign in early January.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.